The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.
The single nucleotide polymorphism 1858C>T in the PTPN22 gene is associated with type 1 diabetes (T1D) in several populations. Earlier reports have suggested that the association may be modified by human leukocyte antigen (HLA), as well as by islet autoantibodies. In a large case-control study of Swedish incident T1D patients and controls, 0-34 years of age, we tested whether the odds ratio (OR) measure of association was dependent on HLA or autoantibodies against the islet autoantigens glutamic acid decarboxylase 65 kDa autoantibodies (GADA), insulin, islet antigen-2, or islet cell. The association between the carrier status of 1858C>T allele in PTPN22 (PTPN22(CT+TT)) and T1D was modified by HLA. In addition, in GADA-positive T1D, the OR was 2.83 (2.00, 3.99), whereas in GADA-negative T1D, the OR was 1.41 (0.98, 2.04) (P for comparison=0.007). The OR of association between PTPN22(CT+TT) and GADA-positive T1D declined with increasing HLA-risk category from 6.12 to 1.54 (P=0.003); no such change was detected in GADA-negative T1D (P=0.722) (P for comparison=0.001). However, the absolute difference in risk between PTPN22(CC) and PTPN22(CT+TT) subjects with high-risk HLA was five times higher than that for subjects with low-risk HLA. We hypothesize that the altered T-cell function because of the PTPN22(1858C>T) polymorphism is exclusively associated with GADA-positive T1D at diagnosis.
Maziarz
M
M
Department of Biostatistics, University of Washington, Seattle, WA 98195-7232, USA. marlenam@u.washington.edu
Janer
M
M
Roach
J C
JC
Hagopian
W
W
Palmer
J P
JP
Deutsch
K
K
Sanjeevi
C B
CB
Kockum
I
I
Breslow
N
N
Lernmark
A
A
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001323:Autoantibodies / Q000276:immunology / Q000378:metabolism*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D055106:Genome-Wide Association Study; D005838:Genotype; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D054596:Protein Tyrosine Phosphatase, Non-Receptor Type 22 / Q000235:genetics*; D018570:Risk Assessment; D013548:Sweden
D001323:Autoantibodies; D006680:HLA Antigens; C516765:PTPN22 protein, human; D054596:Protein Tyrosine Phosphatase, Non-Receptor Type 22; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2
Diabetologia. 2005 Aug;48(8):1484-91
15991024
Eur J Hum Genet. 2006 Mar;14(3):317-21
16391555
Diabetes Care. 2008 Mar;31(3):534-8
18056891
Autoimmunity. 1994;19(2):113-25
7772701
Int J Immunogenet. 2007 Dec;34(6):469-73
18001305
J Immunol Methods. 1988 Jan 21;106(1):83-8
3123555
Eur J Endocrinol. 2005 Dec;153(6):895-9
16322396
Diabetes. 1992 Aug;41(8):1022-7
1628762
Diabetes. 2002 May;51(5):1346-55
11978629
Epidemiology. 1992 Sep;3(5):449-52
1391138
Rheumatology (Oxford). 2008 Feb;47(2):138-41
18156150
Rheumatology (Oxford). 2007 Jan;46(1):49-56
16760194
Tissue Antigens. 2006 May;67(5):430-3
16671953
Eur J Immunogenet. 1999 Apr-Jun;26(2-3):117-27
10331157
Diabetes. 1996 Oct;45(10):1344-9
8826969
Autoimmunity. 2007 Sep;40(6):453-61
17729039
Diabetes. 2005 Dec;54 Suppl 2:S52-61
16306341
Diabetes. 2007 Feb;56(2):522-6
17259401
Diabetes Res Clin Pract. 2007 May;76(2):297-303
17000021
BMC Med Genet. 2007 Aug 13;8:54
17697317
Tissue Antigens. 2008 Nov;72(5):425-30
18764813
DNA Cell Biol. 1994 May;13(5):505-14
8024693
Hum Immunol. 2005 Jan;66(1):60-4
15620463
J Clin Invest. 1995 Apr;95(4):1505-11
7706455
Genes Immun. 2007 Sep;8(6):503-12
17641683
Diabetes. 2008 Jun;57(6):1730-7
18305142
Genes Immun. 2005 Oct;6(7):628-31
16163373
Pediatr Diabetes. 2006 Oct;7(5):274-8
17054449
Diabetologia. 2000 Oct;43(10):1282-92
11079747
Tissue Antigens. 2008 Mar;71(3):234-7
18179648
J Hum Genet. 2005;50(5):264-266
15883854
Ann N Y Acad Sci. 2006 Oct;1079:229-39
17130560
Am J Hum Genet. 2004 Aug;75(2):330-7
15208781
Int J Exp Diabetes Res. 2001;2(2):85-90
12369720
Diabetes. 2008 Jan;57(1):229-34
17934143
J Clin Invest. 1993 Jan;91(1):368-74
8423232
Science. 1983 Dec 23;222(4630):1337-9
6362005
Diabetes. 1995 Jan;44(1):125-31
7813806
Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S116-21
17452059
Eur J Immunogenet. 1999 Oct;26(5):361-72
10553503
J Intern Med. 2003 Apr;253(4):447-53
12653874
Curr Opin Rheumatol. 2009 May;21(3):272-8
19365265
Am J Hum Genet. 2005 Apr;76(4):561-71
15719322
Blood. 1999 Mar 15;93(6):2013-24
10068674
Diabetes. 2004 Nov;53(11):3020-3
15504986
Genes Immun. 2005 Sep;6(6):459-61
15875058
Autoimmun Rev. 2006 Jul;5(6):424-8
16890898
Diabetes. 1992 Feb;41(2):183-6
1733807
Diabetologia. 1994 Apr;37(4):344-50
8063033
Diabetologia. 2006 Jun;49(6):1198-208
16614815
Stat Methods Med Res. 2008 Dec;17(6):595-607
18375456
J Cell Mol Med. 2008 Jun;12(3):1061-2
18194462
Nat Genet. 2004 Apr;36(4):337-8
15004560
Am J Hum Genet. 2001 Apr;68(4):927-36
11254450
Diabetologia. 1987 May;30(5):327-32
3301483